Last updated: December 15, 2023
Sponsor: IRCCS Centro Neurolesi "Bonino-Pulejo"
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Williams Syndrome
Asperger's Disorder
Treatment
TAU
TAU+Multisensory room
Clinical Study ID
NCT06184802
SENSROOM01
Ages 3-6 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients diagnosed with diagnosis of ASD, according to Diagnostic and StatisticalManual of Mental Disorders (DSM-5) criteria;
- age between 3 and 6 years;
- signed informed consent and the availability of at least one family member toparticipate in the diagnostic/therapeutic process.
Exclusion
Exclusion Criteria:
- children not aged between 3 and 6 years;
- significant medical conditions such as epilepsy, significant visual and auditorysensory deficits, traumatic brain injury, or significant genetic disorders.
- Informed consent not signed of at least one family member to participate in thediagnostic/therapeutic process.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: TAU
Phase:
Study Start date:
November 04, 2019
Estimated Completion Date:
January 31, 2025
Study Description
Connect with a study center
IRCCS Neurolesi Bonino Pulejo
Messina, 98124
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.